We use cookies to ensure you get the best experience on our website. Learn more

Get our weekly email

What's inside

Get exclusive insights from industry leaders

"Canopy's intent is to dominate and annihilate everyone else"

Bruce Linton, Canopy Growth CEO

The story of one CEO's plan to disrupt big pharma, a market that was worth $934.8bn last year.

Find out which firm was the first to float on the NASDAQ, seeing its shares instantly jump by over 30%

Learn how one business secured a $3.8bn investment from a global alcoholic beverage company.